During the most recent 90-day period, prior to the date of this filing, there have been 36 insider transactions from the activities of 7 separate insiders all of which have been purchases and resulted in the acquisition of 4,445,250 company shares. Relative to the preceding 90-day window of time, there were 18 transactions from 2 insiders that resulted in the net acquisition of 862,232 shares.
This level of insider transactions is lower than the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 36.5 transactions per company, and disposition of 6,755 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119042002/xslF345X03/doc4.xml
|MSC Industrial Direct's 2020 Estimate Scaled Up but ...|
|2020, and 2021 Earnings Estimates for Morgan Stanley...|
|Medical Finance's Q2, 2020 and 2021 Earnings Estimat...|
|2021, and 2022 Estimates for Methode Electronics Red...|
|2021 Earnings Forecast for K12 Inc Scaled Up|